Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00011297
Status:
COMPLETED
Last Update Posted:
2006-10-23
First Post:
2001-02-15
Brief Title:
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
Sponsor:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Organization:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Study Overview
Official Title:
Alcohol Research Center - Treatment and Implications
Status:
COMPLETED
Status Verified Date:
2006-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate a safe and useful medication for outpatient detoxification that is as effective as benzodiazepines in the short-term and more effective in the protracted withdrawal period Gabapentin Neurontin will be compared to a standard benzodiazepine lorazepam Ativan for its effectiveness in treating alcohol withdrawal
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: